Skip to content

Rehabilitative Efficacy of Multimodal Brain-Based Visual Training on Oculomotor Dysfunction Following Acquired Brain Injury

Rehabilitative Efficacy of Multimodal Brain-Based Visual Training on Oculomotor Dysfunction Following Acquired Brain Injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126663
Enrollment
Unknown
Registered
2026-06-12
Start date
2026-06-12
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

First-ever acquired brain injury (ischemic stroke, hemorrhagic stroke or traumatic brain injury) confirmed by CT/MRI

Interventions

Experimental group:Multimodal brain visual training (integration of multisensory tasks in brain vision
visual fusion training
eye-controlled cognitive training), 5 times per week, 30 minutes each session, for 4 weeks
Control group:Traditional eye movement training (saccadic training, pursuit training, convergence training, and vestibulo-ocular reflex training), 5 times per week, 30 minutes each session, for 4 week

Sponsors

Beijing Bo'ai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 75 years; 2. First-ever acquired brain injury (ischemic stroke, hemorrhagic stroke or traumatic brain injury) confirmed by CT or MRI; 3. Disease course ranging from 1 month to 12 months after onset; 4. Clinically diagnosed oculomotor dysfunction, including slow saccades, interrupted smooth pursuit, unstable fixation, reading difficulty and other related symptoms; 5. Stable vital signs, clear consciousness, and a Mini-Mental State Examination (MMSE) score of >= 17; 6. Able to cooperate with training and assessments, and willing to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. There is a history of other neurological diseases such as Parkinson's disease, epilepsy and Alzheimer's disease in the past; 2. Severe visual impairment (uncorrected visual acuity < 0.1, still < 0.3 after correction) or organic eye diseases such as glaucoma, macular degeneration, and retinal detachment; Staring paralysis, visual field defects and nystagmus; 3. Severe aphasia and cognitive impairment, unable to understand training instructions; 4. Severe limb spasms, pain or orthostatic hypotension that affect sitting training; 5. Is currently participating in other clinical trials related to visual rehabilitation.

Design outcomes

Primary

MeasureTime frame
NSUCO eye movement test;VP-measured fusion (base-in and base-out);Brain Vision oculomotor response time, completion time, and accuracy rate;

Secondary

MeasureTime frame
Reading Efficiency-Developmental Eye Movement Test;Visual Symptoms-Brain Injury Visual Symptom Survey;Quality of Life-National Eye Institute 25-Item Visual Functioning Questionnaire;

Countries

China

Contacts

Public ContactLiu Dama

Beijing Bo'ai Hospital

ldm6505@163.com+86 10 87569232

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026